12:00 AM
 | 
Jul 24, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

V.I. Technologies preclinical data

VITX said that Inactine-treated blood spiked with high concentrations of Yersinia entercolitica bacteria showed no bacterial growth after 28 days of storage versus significant bacterial growth in...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >